A high efficacy DNA vaccine against Tilapia lake virus in Nile tilapia (Oreochromis niloticus)
Authors:
- Nai-Tong YuNai-Tong Yu
- Wei-Wei ZengWZWei-Wei Zeng
- Zhongguo XiongZXZhongguo Xiong
- Zhi-Xin LiuZLZhi-Xin Liu
Open Access
- 12 May 2022
- journal article
- research article
- Published by Elsevier in Aquaculture Reports
- Vol. 24
Abstract
No abstract availableKeywords
All Related Versions
This publication has 29 references indexed in Scilit:
- Detection of Tilapia Lake Virus in Egyptian fish farms experiencing high mortalities in 2015Journal of Fish Diseases, 2017
- Outbreaks of Tilapia Lake Virus Infection, Thailand, 2015–2016Emerging Infectious Diseases, 2017
- Bromodomain Histone Readers and CancerJournal of Molecular Biology, 2017
- BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopesNucleic Acids Research, 2017
- Detection of Tilapia Lake Virus in Clinical Samples by Culturing and Nested Reverse Transcription-PCRJournal of Clinical Microbiology, 2017
- Functions of bromodomain-containing proteins and their roles in homeostasis and cancerNature Reviews Molecular Cell Biology, 2017
- Can water disinfection prevent the transmission of infectious koi herpesvirus to naïve carp? – a case reportJournal of Fish Diseases, 2016
- Identification of a Novel RNA Virus Lethal to TilapiaJournal of Clinical Microbiology, 2014
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Nanogram quantities of a DNA vaccine protect rainbow trout fry against heterologous strains of infectious hematopoietic necrosis virusVaccine, 2000